Abiomed Inc (ABMD)
178.87
-0.88 -0.49%
NASDAQ
Dec 11, 20:00
Delayed 2m
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | 820.28M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | 4.78 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | 220.82M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 82.99% |
| Profit Margin (Quarterly) | 6.38% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | 0.00% |
| Price and Valuation | |
| Market Cap | 8.077B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 10.05 |
| PE Ratio (TTM) | 37.42 |
| Price to Book Value | 8.146 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | 0.00 |
| Free Cash Flow (Quarterly) | 61.90M |
| Return on Equity (TTM) | Upgrade |
View All ABMD News
News
-
WireHeadlineTime (ET)
-
PR Newswire12/12 07:06
-
Yahoo12/11 16:03
-
Yahoo12/11 07:17
-
Yahoo12/04 09:11
-
Yahoo12/04 05:00
-
Yahoo12/03 16:45
-
Yahoo12/03 11:22
-
Yahoo12/03 05:18
-
Yahoo12/02 09:00
-
Yahoo11/29 18:26
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 01/31/2020 08:00 EST | Misc | Abiomed Inc Third Quarter Earnings Conference Call in 2020 |
| 01/31/2020 | Earnings | Abiomed Inc Third Quarter Earnings in 2020 Release |
| 10/31/2019 08:00 EDT | Misc | Abiomed Inc Second Quarter Earnings Conference Call in 2020 |
| 10/31/2019 | Earnings | Abiomed Inc Second Quarter Earnings in 2020 Release |
| 08/07/2019 08:00 EDT | Misc | Abiomed Inc Annual General Meeting in 2019 |
| 08/01/2019 08:00 EDT | Misc | Abiomed Inc First Quarter Earnings Conference Call in 2020 |
| 08/01/2019 | Earnings | Abiomed Inc First Quarter Earnings in 2020 Release |
| 05/23/2019 | Misc | Abiomed Inc Annual Report in 2019 |
| 05/02/2019 08:00 EDT | Misc | Abiomed Inc Fourth Quarter Earnings Conference Call in 2019 |
| 05/02/2019 | Earnings | Abiomed Inc Fourth Quarter Earnings in 2019 Release |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- URL: http://www.abiomed.com
- Investor Relations URL: http://investors.abiomed.com/
- HQ State/Province: Massachusetts
- Sector: Healthcare
- Industry: Medical Devices
- Equity Style: Mid Cap/Growth
- Next Earnings Release: Jan. 31, 2020
- Last Earnings Release: Oct. 31, 2019
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Abiomed Inc provides temporary mechanical circulatory support devices that are primarily used by interventional cardiologists and heart surgeons. The firm's products are primarily used for patients in need of hemodynamic support before, during, or after angioplasty and heart surgery procedures. They work by improving blood flow to coronary arteries or temporarily performing the pumping function of the heart. Abiomed receives the majority of revenue from its Impella product portfolio, which includes percutaneous micro heart pumps with integration motors and sensors and percutaneous catheter-based axial flow pumps. Abiomed generates the majority of its revenue in the United States.
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 178.87 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Top Fund Holders
| Symbol | Name | Weighting |
|---|---|---|
| SLIM | The Obesity ETF | 4.18% |
| NWSAX | Nationwide Small Company Growth A | 3.58% |
| BCSIX | Brown Capital Mgmt Small Co Inv | 2.96% |
| POGRX | PRIMECAP Odyssey Growth | 2.32% |
| POAGX | PRIMECAP Odyssey Aggressive Growth | 2.22% |
| DBMCX | BNY Mellon Sm/Md Cp Gr C | 1.89% |
| IHI | iShares US Medical Devices ETF | 0.86% |
| FCTR | First Trust Lunt US Factor Rotation ETF | 0.85% |
| MIMSX | BNY Mellon Mid Cap Multi-Strategy Inv | 0.62% |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- ABMD Tweets Stocktwits
Advertisement
